![Brent Zanke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brent Zanke
Fondateur chez ArcticDX, Inc.
Postes actifs de Brent Zanke
Sociétés | Poste | Début | Fin |
---|---|---|---|
ArcticDX, Inc.
![]() ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Directeur/Membre du Conseil | 01/01/2006 | - |
Fondateur | 10/06/2010 | - |
Historique de carrière de Brent Zanke
Anciens postes connus de Brent Zanke
Sociétés | Poste | Début | Fin |
---|---|---|---|
CTRL Therapeutics, Inc.
![]() CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Directeur Général | - | - |
Fondateur | - | - | |
Cross Cancer Institute | Directeur/Membre du Conseil | - | - |
Formation de Brent Zanke
University of Manitoba | Doctorate Degree |
University of Toronto | Doctorate Degree |
Statistiques
Internationale
Canada | 6 |
Opérationnelle
Director/Board Member | 2 |
Founder | 2 |
Doctorate Degree | 2 |
Sectorielle
Consumer Services | 3 |
Health Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
ArcticDX, Inc.
![]() ArcticDX, Inc. Medical/Nursing ServicesHealth Services ArcticDX, Inc. designs molecular diagnostic testing services. It provides age-related macular degeneration progression and AMD pharmacogenetics which is used to optimize therapeutic outcomes, determine the appropriate dose for a patient, and avoid harmful effects. The company was founded by Brent Zanke and Gregory C. Hines in 2005 and is headquartered in Toronto, Canada. | Health Services |
Cross Cancer Institute | |
CTRL Therapeutics, Inc.
![]() CTRL Therapeutics, Inc. BiotechnologyHealth Technology CTRL Therapeutics, Inc. engages in the development of liquid biopsy technology. It focuses on the phenotypic properties of tumors and metastatic disease. The company was founded by Brent Zanke and Shana O. Kelley and is headquartered in Toronto, Canada. | Health Technology |
- Bourse
- Insiders
- Brent Zanke
- Expérience